LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,637,860 | +8.2% | 54,159 | +11.2% | 0.00% | 0.0% |
| Q2 2023 | $3,361,001 | -31.3% | 48,689 | -52.0% | 0.00% | -33.3% |
| Q1 2023 | $4,892,401 | -70.0% | 101,460 | -68.9% | 0.01% | -68.4% |
| Q4 2022 | $16,305,610 | +59.6% | 326,651 | +30.5% | 0.02% | +46.2% |
| Q3 2022 | $10,214,000 | +140.0% | 250,336 | +223.6% | 0.01% | +160.0% |
| Q2 2022 | $4,255,000 | +48.5% | 77,356 | -1.9% | 0.01% | +66.7% |
| Q1 2022 | $2,865,000 | -41.6% | 78,842 | -25.1% | 0.00% | -40.0% |
| Q4 2021 | $4,903,000 | – | 105,193 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |